Q1 2024 Holdings
Filed 2024-05-14 | 95 holdings | $807.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $66.4M | 700,000 | 8.2% |
| Moderna Inc(MRNA)Put | COM | 60770K107 | $42.6M | 400,000 | 5.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $39.3M | 592,093 | 4.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $36.0M | 837,387 | 4.5% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $30.7M | 115,000 | 3.8% |
| Teva Pharmaceutical Inds LTD(TEVA)Call | SPONSORED ADS | 881624209 | $23.4M | 1,655,000 | 2.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $22.0M | 470,000 | 2.7% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $21.5M | 3,375,000 | 2.7% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $21.4M | 510,000 | 2.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $20.9M | 300,000 | 2.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $20.3M | 470,000 | 2.5% |
| Inozyme Pharma Inc | COM | 45790W108 | $20.2M | 2,642,519 | 2.5% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $19.8M | 1,400,000 | 2.4% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $18.3M | $17,000,000 | 2.3% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $15.6M | 730,492 | 1.9% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $15.6M | 410,000 | 1.9% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $13.2M | 817,833 | 1.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $12.8M | 82,143 | 1.6% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $12.7M | 300,000 | 1.6% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $11.9M | 810,253 | 1.5% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $11.9M | 845,606 | 1.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $11.3M | 150,000 | 1.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $11.2M | 139,758 | 1.4% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $9.7M | 165,000 | 1.2% |
| Alnylam Pharmaceuticals Inc | NOTE 1.000% 9/1 | 02043QAB3 | $9.4M | $10,000,000 | 1.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $9.4M | 830,546 | 1.2% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $9.2M | 285,000 | 1.1% |
| Ironwood Pharmaceuticals Inc(IRWD)Call | COM CL A | 46333X108 | $9.0M | 1,029,500 | 1.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $8.6M | 1,027,868 | 1.1% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $8.4M | 175,000 | 1.0% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $8.4M | 164,589 | 1.0% |
| Geron Corp(GERN) | COM | 374163103 | $8.3M | 2,500,000 | 1.0% |
| Morphic Hldg Inc | COM | 61775R105 | $7.9M | 225,000 | 1.0% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $7.7M | 250,000 | 1.0% |
| Omeros Corp | NOTE 5.250% 2/1 | 682143AG7 | $7.6M | $10,500,000 | 0.9% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $6.8M | 286,200 | 0.8% |
| Elevation Oncology Inc | COM | 28623U101 | $6.5M | 1,268,825 | 0.8% |
| Gritstone BIO Inc(2JQ)Put | COM | 39868T105 | $6.1M | 2,390,600 | 0.8% |
| Perspective Therapeutics Inc | COM | 46489V104 | $6.1M | 5,100,000 | 0.8% |
| Alnylam Pharmaceuticals Inc(ALNY)Call | COM | 02043Q107 | $6.0M | 40,000 | 0.7% |
| Absci Corporation(ABSI) | COM | 00091E109 | $5.8M | 1,025,000 | 0.7% |
| Coherus Biosciences Inc | NOTE 1.500% 4/1 | 19249HAB9 | $5.8M | $9,000,000 | 0.7% |
| Savara Inc(SVRA) | COM | 805111101 | $5.7M | 1,150,000 | 0.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $5.6M | 80,000 | 0.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $5.5M | 80,000 | 0.7% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $5.3M | 500,000 | 0.7% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $5.2M | 550,339 | 0.6% |
| Rapt Therapeutics Inc(RAPTEUR)Put | COM | 75382E109 | $5.2M | 577,100 | 0.6% |
| Guardant Health Inc(GH)Call | COM | 40131M109 | $5.2M | 250,000 | 0.6% |
| Springworks Therapeutics Inc | COM | 85205L107 | $4.9M | 100,000 | 0.6% |